Tender

UK Domestic Plasma Fractionation Service

NHS ENGLAND

This public procurement record has 1 release in its history.

Tender

11 Apr 2022 at 17:41

Tender Notice
Summary of the contracting process

The procurement process involves NHS England, which is seeking a supplier for the "UK Domestic Plasma Fractionation Service." This project falls under the healthcare industry, specifically involving immunoglobulins, and is located in the United Kingdom. Currently in the Tender stage, this competitive dialogue process aims to select a single organisation to provide a toll fractionation service using UK plasma. Key dates include the deadline for completing the Selection Questionnaire on 12th May 2022, with the contract period set to run from 1st November 2022 until 31st October 2027.

This tender presents significant opportunities for businesses that specialise in plasma fractionation and related services, particularly those capable of meeting the specific needs outlined by NHS England. Companies experienced in manufacturing medicinal products from plasma or those with expertise in health service collaborations may find this a suitable opportunity to participate in a strategic initiative aimed at achieving partial self-sufficiency for the NHS. Engaging in this procurement could enhance their visibility and market position within the UK healthcare system while contributing to public health outcomes.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

UK Domestic Plasma Fractionation Service

Notice Description

NHS England and NHS Improvement (NHSE&I) in conjunction with NHS Blood and Transplant (NHSBT) issued Prior Information Notices (PIN) in August 2021 and January 2022, seeking to gather information and feedback from the plasma fractionation market, as recognised experts, to help inform the strategy to contract for fractionation services using UK plasma. Having reflected upon the feedback received, NHSE&I is now commencing a Competitive Dialogue process, to select a single organisation to provide a toll fractionation service using UK plasma. The UK recognises that medicinal products derived from UK plasma have not been manufactured for more than 20 years. As such there is a much to learn and/or relearn. This procurement, and the wider project its supports, are therefore seen as the UK's initial step (or pilot project) to achieve partial self-sufficiency for plasma derived medicinal products for the exclusive use of NHS patients in the UK. As such, this procurement is not expected to be a one off exercise. Rather the learning from this project is expected to inform future procurements and how the UK works with selected fractionators to achieve its long term ambitions for self-sufficiency. As regards Northern Ireland, Scotland and Wales, the respective Blood Services (represented by their hosting bodies where applicable) for each of the regions have expressed interest in this procurement. Therefore the Blood Services for each region (including their hosting bodies where applicable), the Devolved Administration for each region and the NHS providers in each region (as potential buyers of products derived from fractionation) are included by NHSE&I as Participating Authorities ("PAs") within this Contract Notice, as further defined in the tender documents. This provides an option for each of the above bodies to be a party to the contractual arrangements that will result from this procurement (by entering into essentially identical but separate contracts, under the law and jurisdiction of the relevant region in each case), but does not bind them to do so. Further details of the decision and implementation processes for the PAs in Northern Ireland, Scotland and Wales will be provided during the next stage of this procurement (Invitation to Participate in Dialogue The Authority and PA's reserve the right to amend any plasma volumes stated within the procurement documents. Interested organisations can register their interest and access the procurement documents for full details here https://health-family.force.com/s/Welcome Once registered, you will be invited to sign a tripartite non-disclosure agreement (NDA). If you have previously signed an NDA as part of the 2 PIN notices issued for this tender, the NDA continues to apply during the tender period and until a contract has been entered into. The deadline for completion of the Selection Questionnaire within Atamis is 12th May 2022 at 13:00hrs

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/58ec297b-7c1b-433a-b1d0-1dab0fabe8a3
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Selective
Procurement Method Details
Competitive dialogue (above threshold)
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651520 - Immunoglobulins

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
11 Apr 20223 years ago
Submission Deadline
12 May 2022Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Nov 2022 - 31 Oct 2027 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Post Town
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a-2022-04-11T18:41:13+01:00",
    "date": "2022-04-11T18:41:13+01:00",
    "ocid": "ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CF-0769100D0O000000rwimUAA1",
        "title": "UK Domestic Plasma Fractionation Service",
        "description": "NHS England and NHS Improvement (NHSE&I) in conjunction with NHS Blood and Transplant (NHSBT) issued Prior Information Notices (PIN) in August 2021 and January 2022, seeking to gather information and feedback from the plasma fractionation market, as recognised experts, to help inform the strategy to contract for fractionation services using UK plasma. Having reflected upon the feedback received, NHSE&I is now commencing a Competitive Dialogue process, to select a single organisation to provide a toll fractionation service using UK plasma. The UK recognises that medicinal products derived from UK plasma have not been manufactured for more than 20 years. As such there is a much to learn and/or relearn. This procurement, and the wider project its supports, are therefore seen as the UK's initial step (or pilot project) to achieve partial self-sufficiency for plasma derived medicinal products for the exclusive use of NHS patients in the UK. As such, this procurement is not expected to be a one off exercise. Rather the learning from this project is expected to inform future procurements and how the UK works with selected fractionators to achieve its long term ambitions for self-sufficiency. As regards Northern Ireland, Scotland and Wales, the respective Blood Services (represented by their hosting bodies where applicable) for each of the regions have expressed interest in this procurement. Therefore the Blood Services for each region (including their hosting bodies where applicable), the Devolved Administration for each region and the NHS providers in each region (as potential buyers of products derived from fractionation) are included by NHSE&I as Participating Authorities (\"PAs\") within this Contract Notice, as further defined in the tender documents. This provides an option for each of the above bodies to be a party to the contractual arrangements that will result from this procurement (by entering into essentially identical but separate contracts, under the law and jurisdiction of the relevant region in each case), but does not bind them to do so. Further details of the decision and implementation processes for the PAs in Northern Ireland, Scotland and Wales will be provided during the next stage of this procurement (Invitation to Participate in Dialogue The Authority and PA's reserve the right to amend any plasma volumes stated within the procurement documents. Interested organisations can register their interest and access the procurement documents for full details here https://health-family.force.com/s/Welcome Once registered, you will be invited to sign a tripartite non-disclosure agreement (NDA). If you have previously signed an NDA as part of the 2 PIN notices issued for this tender, the NDA continues to apply during the tender period and until a contract has been entered into. The deadline for completion of the Selection Questionnaire within Atamis is 12th May 2022 at 13:00hrs",
        "datePublished": "2022-04-11T18:41:13+01:00",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "33651520",
            "description": "Immunoglobulins"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "LS2 7UE"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "procurementMethod": "selective",
        "procurementMethodDetails": "Competitive dialogue (above threshold)",
        "tenderPeriod": {
            "endDate": "2022-05-12T13:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2022-11-01T00:00:00Z",
            "endDate": "2027-10-31T23:59:59Z"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/58ec297b-7c1b-433a-b1d0-1dab0fabe8a3",
                "datePublished": "2022-04-11T18:41:13+01:00",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-158202",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House",
                "locality": "Leeds",
                "postalCode": "LS2 7UE",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Liz Fleetwood",
                "email": "liz.fleetwood1@nhs.net"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-158202",
        "name": "NHS England"
    }
}